Literature DB >> 19468241

FYN kinase gene: another glutamatergic gene associated with bipolar disorder?

Aleksandra Szczepankiewicz1, Janusz K Rybakowski, Maria Skibinska, Monika Dmitrzak-Weglarz, Anna Leszczynska-Rodziewicz, Monika Wilkosc, Joanna Hauser.   

Abstract

Several genes of the glutamatergic system have been implicated in both schizophrenia and bipolar disorder. The Src family tyrosine kinase FYN plays a key role in the interaction between brain-derived neurotrophic factor and glutamatergic receptor N-methyl-D-aspartate. Although no association between FYN gene polymorphisms and schizophrenia has been demonstrated, in our previous paper we found an association between FYN polymorphisms and cognitive test performance in schizophrenic patients. The aim of this study was to find a possible association of three polymorphisms of the FYN gene with bipolar disorder. We analyzed 425 bipolar patients and 518 control subjects. Genotypes of three analyzed polymorphisms, i.e. rs706895 (-93A/G in the 5'-flanking region), rs6916861 (Ex12+894T/G in the 3'-UTR) and rs3730353 (IVS10+37T/C in intron 10) were established by PCR-RFLP. A significant association was found between rs6916861 T/G and rs3730353 T/C polymorphisms of the FYN gene and bipolar disorder. These results were also significant in the subgroups of bipolar I and early-onset (<18 years) bipolar disorder patients. No association with -93 A/G polymorphism was found. Haplotype analysis revealed that rs6916861 T/G and rs3730353 T/C polymorphisms are in linkage disequilibrium (r(2) = 0.86, D' = 0.93 with 95% CI = 0.9-0.97). The results suggest that the glutamatergic FYN gene may be associated with bipolar disorder, particularly with type I illness and early age of onset. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468241     DOI: 10.1159/000219305

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  11 in total

1.  The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Robert J Rooney; Susumu Mori; Tess E Kornfield; Teri J Reutiman; Rachel E Kneeland; Stephanie B Liesch; Kegang Hua; John Hsu; Divyen H Patel
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

2.  Fyn polymorphisms are associated with distinct personality traits in healthy Chinese-Han subjects.

Authors:  Jingying Li; Huan Ma; Shumin Deng; Lijuan Wu; Yinglin Huang; Gang Zhu
Journal:  J Mol Neurosci       Date:  2011-01-05       Impact factor: 3.444

Review 3.  Response to treatment in bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Guy Rouleau; Gustavo Turecki
Journal:  Curr Opin Psychiatry       Date:  2011-01       Impact factor: 4.741

Review 4.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

5.  Fyn and Lyn gene polymorphisms impact the risk of thyroid cancer.

Authors:  Asif Nisar; Mahmood Akhtar Kayani; Wajiha Nasir; Azhar Mehmood; Malik Waqar Ahmed; Aamir Parvez; Ishrat Mahjabeen
Journal:  Mol Genet Genomics       Date:  2022-09-04       Impact factor: 2.980

6.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

Review 7.  Response to lithium in bipolar disorder: clinical and genetic findings.

Authors:  Janusz K Rybakowski
Journal:  ACS Chem Neurosci       Date:  2014-03-25       Impact factor: 4.418

Review 8.  Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

Authors:  Rafael T de Sousa; Alexandre A Loch; André F Carvalho; André R Brunoni; Marie Reine Haddad; Ioline D Henter; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Neuropsychopharmacology       Date:  2016-08-11       Impact factor: 7.853

9.  Cross-domain neurobiology data integration and exploration.

Authors:  Weijian Xuan; Manhong Dai; Josh Buckner; Barbara Mirel; Jean Song; Brian Athey; Stanley J Watson; Fan Meng
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

Review 10.  Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.

Authors:  Janusz K Rybakowski
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.